Position in STRO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,982,000
+$2,668,000 QoQ
Shares Held
200,000
0.0% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in STRO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,982,000 | 200,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,314,000 | 200,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,740,000 | 2,000,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,420,000 | 2,000,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,300,000 | 2,000,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,680,000 | 2,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,785,456 | 2,250,132 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,860,000 | 2,000,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,300,000 | 2,000,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,166,844 | 4,467,796 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,774,808 | 3,105,132 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,049,598 | 225,720 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $257,426 | 55,720 | Shares | Sole | 2023-05-15 | |
| 2021-12-31 | $2,380,800 | 160,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,194,750 | 275,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,041,750 | 325,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,248,828 | 450,300 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,312,250 | 475,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,286,250 | 725,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,626,000 | 725,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,335,000 | 425,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||